
Ardin H. Marschel
Examiner (ID: 15670)
| Most Active Art Unit | 1631 |
| Art Unit(s) | 1634, 1635, 1655, 1744, 1614, 1803, 1631, 1637, 1636, 2899, 1809, 1611, 1807 |
| Total Applications | 1516 |
| Issued Applications | 761 |
| Pending Applications | 308 |
| Abandoned Applications | 447 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7527472
[patent_doc_number] => 08044064
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-25
[patent_title] => 'Fused pyrrolocarbazoles'
[patent_app_type] => utility
[patent_app_number] => 12/708306
[patent_app_country] => US
[patent_app_date] => 2010-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41797
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/044/08044064.pdf
[firstpage_image] =>[orig_patent_app_number] => 12708306
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/708306 | Fused pyrrolocarbazoles | Feb 17, 2010 | Issued |
Array
(
[id] => 6569994
[patent_doc_number] => 20100234472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'NITRIC OXIDE RELEASING DERIVATIVES OF PARACETAMOL'
[patent_app_type] => utility
[patent_app_number] => 12/707410
[patent_app_country] => US
[patent_app_date] => 2010-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8253
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20100234472.pdf
[firstpage_image] =>[orig_patent_app_number] => 12707410
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/707410 | Nitric oxide releasing derivatives of paracetamol | Feb 16, 2010 | Issued |
Array
(
[id] => 4432343
[patent_doc_number] => 07968589
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-28
[patent_title] => 'Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use'
[patent_app_type] => utility
[patent_app_number] => 12/702358
[patent_app_country] => US
[patent_app_date] => 2010-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23373
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/968/07968589.pdf
[firstpage_image] =>[orig_patent_app_number] => 12702358
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/702358 | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use | Feb 8, 2010 | Issued |
Array
(
[id] => 6289382
[patent_doc_number] => 20100158798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'FP-Pocket-Binding Effectors and Methods for Using the Same to Modulate Telomerase Activity'
[patent_app_type] => utility
[patent_app_number] => 12/701947
[patent_app_country] => US
[patent_app_date] => 2010-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17546
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20100158798.pdf
[firstpage_image] =>[orig_patent_app_number] => 12701947
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/701947 | FP-pocket-binding effectors and methods for using the same to modulate telomerase activity | Feb 7, 2010 | Issued |
Array
(
[id] => 8104049
[patent_doc_number] => 08153673
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-10
[patent_title] => 'Metalloproteinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/693852
[patent_app_country] => US
[patent_app_date] => 2010-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14817
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/153/08153673.pdf
[firstpage_image] =>[orig_patent_app_number] => 12693852
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/693852 | Metalloproteinase inhibitors | Jan 25, 2010 | Issued |
Array
(
[id] => 6388838
[patent_doc_number] => 20100317710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => '3-(3-INDOLYL) PROPIONIC ACID CALCIUM SALT AND METHOD OF MAKING 3-(3-INDOLYL) PROPIONIC ACID FREE ACID THEREFROM'
[patent_app_type] => utility
[patent_app_number] => 12/691067
[patent_app_country] => US
[patent_app_date] => 2010-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6957
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317710.pdf
[firstpage_image] =>[orig_patent_app_number] => 12691067
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/691067 | 3-(3-INDOLYL) PROPIONIC ACID CALCIUM SALT AND METHOD OF MAKING 3-(3-INDOLYL) PROPIONIC ACID FREE ACID THEREFROM | Jan 20, 2010 | Abandoned |
Array
(
[id] => 8533581
[patent_doc_number] => 08309738
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-13
[patent_title] => 'Methods for the preparation of thiazolidinethione indene-based chiral auxiliaries'
[patent_app_type] => utility
[patent_app_number] => 12/685014
[patent_app_country] => US
[patent_app_date] => 2010-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7683
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12685014
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/685014 | Methods for the preparation of thiazolidinethione indene-based chiral auxiliaries | Jan 10, 2010 | Issued |
Array
(
[id] => 7511516
[patent_doc_number] => 20110257226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'HALOGEN-CONTAINING ORGANOSULFUR COMPOUND AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/141643
[patent_app_country] => US
[patent_app_date] => 2009-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44967
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20110257226.pdf
[firstpage_image] =>[orig_patent_app_number] => 13141643
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/141643 | Halogen-containing organosulfur compound and use thereof | Dec 23, 2009 | Issued |
Array
(
[id] => 8630194
[patent_doc_number] => 08362266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-29
[patent_title] => 'Method of manufacturing a ruthenium complex'
[patent_app_type] => utility
[patent_app_number] => 12/636025
[patent_app_country] => US
[patent_app_date] => 2009-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2213
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12636025
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/636025 | Method of manufacturing a ruthenium complex | Dec 10, 2009 | Issued |
Array
(
[id] => 4432744
[patent_doc_number] => 07968730
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-28
[patent_title] => 'Synthesis of amines and intermediates for the synthesis thereof'
[patent_app_type] => utility
[patent_app_number] => 12/631894
[patent_app_country] => US
[patent_app_date] => 2009-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23161
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/968/07968730.pdf
[firstpage_image] =>[orig_patent_app_number] => 12631894
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/631894 | Synthesis of amines and intermediates for the synthesis thereof | Dec 6, 2009 | Issued |
Array
(
[id] => 6592719
[patent_doc_number] => 20100130582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'INDOLINONE MODULATORS OF DOPAMINE RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 12/624618
[patent_app_country] => US
[patent_app_date] => 2009-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11068
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20100130582.pdf
[firstpage_image] =>[orig_patent_app_number] => 12624618
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/624618 | INDOLINONE MODULATORS OF DOPAMINE RECEPTOR | Nov 23, 2009 | Abandoned |
Array
(
[id] => 4599947
[patent_doc_number] => 07977380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-12
[patent_title] => 'Inhibitors of plasma kallikrein'
[patent_app_type] => utility
[patent_app_number] => 12/623326
[patent_app_country] => US
[patent_app_date] => 2009-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14222
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/977/07977380.pdf
[firstpage_image] =>[orig_patent_app_number] => 12623326
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/623326 | Inhibitors of plasma kallikrein | Nov 19, 2009 | Issued |
Array
(
[id] => 7550706
[patent_doc_number] => 08063039
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-22
[patent_title] => '3-aminopyrrolidone derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/610660
[patent_app_country] => US
[patent_app_date] => 2009-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8338
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/063/08063039.pdf
[firstpage_image] =>[orig_patent_app_number] => 12610660
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/610660 | 3-aminopyrrolidone derivatives | Nov 1, 2009 | Issued |
Array
(
[id] => 7545023
[patent_doc_number] => 08052993
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-08
[patent_title] => '3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)'
[patent_app_type] => utility
[patent_app_number] => 12/607291
[patent_app_country] => US
[patent_app_date] => 2009-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7695
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/052/08052993.pdf
[firstpage_image] =>[orig_patent_app_number] => 12607291
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/607291 | 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) | Oct 27, 2009 | Issued |
Array
(
[id] => 6578492
[patent_doc_number] => 20100047347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => '3\'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2\'-hydroxy-[1,1\'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)'
[patent_app_type] => utility
[patent_app_number] => 12/607320
[patent_app_country] => US
[patent_app_date] => 2009-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7696
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20100047347.pdf
[firstpage_image] =>[orig_patent_app_number] => 12607320
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/607320 | 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1 ,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) | Oct 27, 2009 | Issued |
Array
(
[id] => 6468259
[patent_doc_number] => 20100040683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => '3\'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2\'-hydroxy-[1,1\'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)'
[patent_app_type] => utility
[patent_app_number] => 12/607284
[patent_app_country] => US
[patent_app_date] => 2009-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7696
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20100040683.pdf
[firstpage_image] =>[orig_patent_app_number] => 12607284
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/607284 | 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) | Oct 27, 2009 | Issued |
Array
(
[id] => 7545024
[patent_doc_number] => 08052994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-08
[patent_title] => '3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)'
[patent_app_type] => utility
[patent_app_number] => 12/607305
[patent_app_country] => US
[patent_app_date] => 2009-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7695
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/052/08052994.pdf
[firstpage_image] =>[orig_patent_app_number] => 12607305
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/607305 | 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) | Oct 27, 2009 | Issued |
Array
(
[id] => 7545025
[patent_doc_number] => 08052995
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-08
[patent_title] => '3\'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2\'-hydroxy-[1,1\'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)'
[patent_app_type] => utility
[patent_app_number] => 12/607330
[patent_app_country] => US
[patent_app_date] => 2009-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7695
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/052/08052995.pdf
[firstpage_image] =>[orig_patent_app_number] => 12607330
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/607330 | 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) | Oct 27, 2009 | Issued |
Array
(
[id] => 6280949
[patent_doc_number] => 20100119623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'IMIDAZOLYL MODULATORS OF 5-HT3 RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 12/560939
[patent_app_country] => US
[patent_app_date] => 2009-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11914
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20100119623.pdf
[firstpage_image] =>[orig_patent_app_number] => 12560939
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/560939 | IMIDAZOLYL MODULATORS OF 5-HT3 RECEPTORS | Sep 15, 2009 | Abandoned |
Array
(
[id] => 6479094
[patent_doc_number] => 20100041707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'INHIBITORS OF ION CHANNELS'
[patent_app_type] => utility
[patent_app_number] => 12/561002
[patent_app_country] => US
[patent_app_date] => 2009-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18756
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20100041707.pdf
[firstpage_image] =>[orig_patent_app_number] => 12561002
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/561002 | Inhibitors of ion channels | Sep 15, 2009 | Issued |